amino acid peptides followed by a stop codon. The 125 amino acid C-terminal fragment of CAPON specifically interacts with nNOS in the two-hybrid system as is evident from the failure of CAPON to interact with fragments of PSD93 and PSD95 containing PDZ domains ( Figure 1A ). Moreover, nNOS fails to interact with another control protein, c-fos. To obtain a full-length CAPON cDNA, we screened a rat brain cDNA library with the larger two-hybrid clone and isolated a 2100 bp cDNA that overlapped with the two-hybrid clone and was used to assemble a final 2820 bp cDNA (see Experimental Procedures). The conceptual translation of this cDNA produces a 503 amino acid protein ( Figure 1B ). The first ATG in the cDNA was 393 bp from the 5Ј end of the cDNA and was situated in a context that conformed to the Kozak consensus sequence for an initiator methionine (Kozak, 1991) .
CAPON displays no significant homology to any other known class of protein except for an N-terminal 145 amino acid stretch of amino acids that has residues suggestive of a phosphotyrosine-binding (PTB) domain (Zhou et al., 1995) . CAPON's PTB domain most closely resembles the mouse numb protein's PTB domain (Zhong et al., 1996) , with nearly 28% sequence identity on this region. The similarity between CAPON and numb is limited to this domain. PTB domains are targeted to phosphotyrosine-containing proteins such as growth factor receptors (reviewed in van der Geer and Pawson, 1995) .
Outside of the PTB domain, CAPON lacks any wellknown consensus sequences except for an 18 nucleotide stretch of CAG repeats that corresponds to six glutamines. Glutamine repeats occur in proteins whose expansion results in neurodegenerative diseases as exemplified by huntingtin, the protein that is altered in Huntington's disease (Ross, 1995) . A BLAST search (Altschul et al., 1990) of an expressed sequence tag database, dBEST, reveals a human brain-derived EST with ‫%57ف‬ nucleotide identity to CAPON. The cDNA forms of NOS were incubated with GST-CAPON. After extensive washing of the resin, bound nNOS was detected by Western blotting with the appropriate isoform-specific antibody. nNOS interacts strongly with GST-CAPON, Figure 2 . Interaction of CAPON and nNOS (A) CAPON binds to nNOS but not eNOS or iNOS. Bacterially expressed GST, GST-PIN, and GST-CAPON were bound to glutathione agarose and then incubated with lysates of HEK-293 cells transfected with expression plasmids for the indicated isoforms of NOS. After extensive washing of the resins, bound NOS was detected with isoform-specific antibodies. While nNOS binds to both GST-PIN and GST-CAPON, neither eNOS or iNOS binds to either protein. Input ϭ 10% of starting material applied to each resin. (B) A GST-NOS fusion protein specifically binds to rat brain CAPON. A fusion protein consisting of GST and amino acids 1-100 of nNOS was bound to glutathione agarose and then incubated with cerebellar supernatants. After extensive washing, CAPON is detected on the NOS resin but not on the control GST resin. A second ‫84ف‬ kDa band is also detected with this antibody but fails to interact with nNOS. This band may represent a cross-reactive protein, an alternatively spliced isoform of CAPON, or a degradation product. (C) CAPON interacts with nNOS directly. HEK-293 lysates transfected with a expression plasmid containing the nNOS cDNA or empty vector were resolved by electrophoresis, transferred to nitrocellulose, and probed with radiolabeled CAPON (see Experimental Procedures). Purified nNOS is recognized with this probe, along with a comigrating band detected in NOS-transfected but not mock-transfected cells. (D) CAPON and nNOS complexes are detectable in cerebellar lysates (I). Cerebellar supernatants were prepared from wild-type (ϩ/ϩ) and nNOS knockout (Ϫ/Ϫ) mice and incubated with 2Ј,5Ј-ADP-Sepharose, an nNOS affinity resin. Only CAPON derived from supernatants of wildtype and not knockout animals was capable of binding the resin, indicating that the presence of nNOS is required for CAPON to bind to the resin. CAPON levels were decreased in knockout animals, presumably due to decreased stability in the absence of the nNOS-binding partner. A lower molecular weight band (arrowhead), frequently detected with the anti-CAPON antibody, bound weakly to the resin in an nNOS-specific manner as well. Input ϭ 20% of lysate used for binding. (E) CAPON and nNOS complexes are detectable in cerebellar lysates (II). An antibody to CAPON (5 g) specifically coprecipitates nNOS, while comparable amounts of antibody to the G protein subunit ␤1, cyclin-dependent kinase 2, and preimmune serum fail to coprecipitate nNOS. Enrichment of nNOS in CAPON immunoprecipitates was specific, as a control protein, protein kinase C-␤ I/II, did not display similar enrichment. Input ϭ 10% of lysate used for immunoprecipitation.
while eNOS and iNOS do not interact. No interactions GST-nNOS fusion proteins ( Figure 2B ) and may represent an unrelated cross-reactive protein or the product are evident with the GST control.
We also examined interactions of CAPON and nNOS of an alternatively spliced CAPON mRNA that fails to bind nNOS. by utilizing a GST fusion protein of the N-terminal 100 amino acids of nNOS, the PDZ domain. Following incu-
The protein-protein interactions we detected with cell lysates and GST fusion proteins may reflect a tertiary bation with cerebellar lysates, the washed GST-nNOS resin was subjected to SDS-PAGE and Western blotted interaction between nNOS, an unidentified protein, and CAPON. To determine if CAPON directly binds to nNOS, with a purified antibody directed against the C-terminal 125 amino acids of CAPON. A single band correspondwe conducted blot overlay experiments ( Figure 2C Figure 3A ) Rodrigo et al., 1994) . CAPON immunoreactivity displays simnNOS.
To ascertain if complexes of CAPON and nNOS exist ilar distributions, with highest levels in the olfactory bulb and cerebellum like nNOS ( Figure 3A) . We also localized physiologically, we used two approaches. Our first approach took advantage of a NOS affinity resin consisting CAPON mRNA by in situ hybridization using a probe directed against the 3Ј region of the CAPON open readof 2Ј, 5Ј-ADP ribose crosslinked to an agarose matrix. This resin has been used previously to purify nNOS from ing frame. CAPON mRNA densities were especially prominent in the accessory and main olfactory bulbs, cerebellar supernatants . Following incubation with cerebellar supernatants, the resin as well as the hippocampus, cortex, and cerebellum. High-power immunohistochemical studies reveal that was washed extensively. As expected, a significant portion of the nNOS found in the starting material was CAPON and nNOS exhibit numerous colocalizations throughout the brain. The supraoptic nucleus stains inbound to the resin ( Figure 2D ). To determine if nNOS and CAPON were physiologically associated, we next tensely for both CAPON and nNOS ( Figure 3B ). The nucleus of the trapezoid body contains CAPON-positive assayed for CAPON bound to the resin. Like nNOS, CAPON was substantially enriched in the bound fraction.
and nNOS-positive cell bodies separated by unreactive fascicles of nerve fibers ( Figure 3B ). The adjacent ponAs a control, we assayed for the resin-binding ability of CAPON from supernatants derived from mice with a tine nucleus also exhibits CAPON and nNOS immunoreactivity of its small neuronal cell bodies ( Figure 3B ). genomic deletion of nNOS. These mice express a truncated version of nNOS that lacks the PDZ domain and
In the cerebellum, Purkinje cells fail to stain for either CAPON or nNOS. The neuropil of the molecular cell is unable to bind CAPON. Substantially less CAPON in these supernatants bound to the 2Ј, 5Ј-ADP ribose resin, layer stains intensely for both CAPON and nNOS. There are exceptions to CAPON-nNOS colocalizations. For indicating that CAPON has negligible intrinsic affinity for the resin and that CAPON binding in wild-type supernaexample, the granular cell layer of the cerebellum exhibits strong nNOS staining but weak CAPON staining tants was due to nNOS. The smaller cross-reactive band was also enriched on this resin, supporting the notion ( Figure 3B ). Under higher magnification, we find that CAPON, like that it is in some manner related to CAPON by alternative splicing or proteolytic degradation. Interestingly, the tonNOS, is detected only in neurons, with labeling of both the soma and processes ( Figure 3B ). All immunoreactivtal level of CAPON in knockout supernatants was approximately one half that in wild-type mice, possibly due ity is abolished by preabsorption of the CAPON antiserum with the antigenic peptide overnight before incubato the absence of a stabilizing effect of nNOS.
As a second approach, we immunoprecipitated CAPON tion with brain sections ( Figure 3A ). from cerebellar supernatants and assayed for nNOS by Western blot ( Figure 2E ). nNOS coprecipitates with antiThe C Terminus of CAPON Binds to the PDZ CAPON antibodies but is not detected in immunoprecipDomain of nNOS itates generated using preimmune serume, an antibody
To examine the region of nNOS that binds to CAPON, we to the G protein subunit ␤1, or with an antibody to cyclinconducted yeast two-hybrid experiments with various dependent kinase 2. To determine if the enrichment obtruncations of nNOS ( Figure 4A ). As little as the first 100 served in anti-CAPON immunoprecipitates was specific, amino acids of nNOS binds to the C-terminal 125 amino we asked if a control protein, protein kinase C-␤ I/II, acids of CAPON. This portion of nNOS contains the full was similarly enriched in these fractions. We found that PDZ domain as defined by MacKinnon and associates this protein was absent in all of the precipitates (Figure (Doyle et al., 1996) , who identified the PDZ consensus 2E), indicating that the coprecipitation of nNOS with domain in nNOS as amino acids 14-89. Deletion of the CAPON was specific. These two approaches support first 20 amino acids of nNOS, which include the first the notion that CAPON and NOS exist as a complex in seven amino acids of the PDZ domain, does not abolish the rat cerebellum.
binding, but larger N-terminal deletions abolish binding, In other experiments, we metabolically labeled N1E-presumably because they result in a loss of important 115 mouse neuroblastoma cells with [
35 S]methionine structural components of the PDZ domain. The nNOS and examined for the presence of proteins that would construct comprising amino acids 163-245, which repbind to GST-CAPON. The only protein that specifically resents the PIN-binding domain of nNOS (Jaffrey and interacted with CAPON is a 160 kDa protein that comiSnyder, 1996) , shows no interaction with CAPON. grates with an nNOS standard (unpublished data), sug-PDZ domains typically interact with a characteristic gesting that nNOS is the most abundant CAPON-binding C-terminal motif in other proteins (Songyang et al., protein in these cells. 1997) . By contrast, the nNOS PDZ domain binds directly to other PDZ domains, such as those in PSD95, but has CAPON and nNOS Are Colocalized in Rat Brain not previously been reported to interact with any known To clarify further the relationship between nNOS and physiological C-terminal peptide motifs. Since we could CAPON, we compared their distributions in the brain by not detect any PDZ domain motifs in the CAPON seimmunohistochemistry ( Figures 3A and 3B ). Our localquence, we sought to determine the region in CAPON izations of nNOS are identical to those previously rethat accounted for nNOS binding. We investigated the ported, with high levels of immunoreactivity in the accessory olfactory bulb, caudate-putamen, cerebellum, domain of CAPON that interacts with nNOS using GST- . After extensive washing of the resin, we assayed that the C-terminal portion of CAPON is necessary and for nNOS bound to PSD95 by Western blot. As little as sufficient for nNOS binding.
5 nM His6-CAPON causes a substantial reduction of Recently, Cantley and associates (Songyang et al., nNOS binding to GST-PSD95. Half-maximal reduction 1997) identified consensus sequences for binding to of binding is evident between 5 and 50 nM His 6 -CAPON several PDZ domains. Binding of PDZ ligands involves ( Figure 5B ). Deletion of the C-terminal 20 amino acids the C terminus of proteins, with determinants of specificof CAPON abolishes its ability to serve as a competitor ity lying within the eight or fewer C-terminal amino acids.
for nNOS binding to GST-PSD95. As controls, we exam-A consistent requirement among all the PDZ domain ined the effects of 5 M His 6-PIN or 5 M His6-FK506 ligands is a hydrophobic residue, such as valine or leubinding protein-12 (FKBP). Neither of these proteins cine, as the final amino acid. To determine if the binding competes for binding to nNOS. nNOS also binds to the of CAPON to nNOS exhibits similar sequence specificity, second PDZ domain of PSD93, a protein that is highly we examined the binding of mutagenized His 6-CAPON homologous to PSD95 (Brenman et al., 1996b) . His 6-fusion proteins to immobilized GST-nNOS PDZ domain CAPON is an effective competitor for nNOS binding to fusion proteins ( Figure 4C ). The C-terminal residue of immobilized GST-PSD93 as well ( Figures 5A and 5B ). CAPON is a valine, and conversion of this residue to These effects of CAPON likely reflect its binding to nNOS alanine abolishes binding. Binding is also greatly rerather than to the PDZ domains of either PSD95 or duced by changing the penultimate amino acid from PSD93 because CAPON fails to interact with either alanine to aspartate. However, changing the n-2 amino PSD93 or PSD95 using a two-hybrid assay (see Figure  acid from GST-PSD93 (116-421), the regions of these proteins having been of CAPON previously shown to interact with nNOS (Brenman et al., 1996) . The disruption of the nNOS/PSD95 interaction required the C-terminal (A) The PDZ domain of nNOS (amino acids 20-100) is sufficient for 13 amino acids, as this fusion protein (⌬C20) fails to block the binding to CAPON. Truncations of nNOS were subcloned into the interaction even at 5 M. Other control proteins such as His6-PIN GAL4 BD vector, and nNOS/CAPON interactions were detected by or His 6-FKBP do not disrupt the nNOS/PSD95 interaction. ␤-galactosidase assays.
(B) Quantification of CAPON inhibition of the nNOS/PSD95 interac-(B) The C-terminal 13 amino acids of CAPON are sufficient for bindtion. HEK-293 cells were transfected with nNOS expression plasing to nNOS. Various GST-CAPON fusion proteins were incubated mids and then metabolically labeled with [ 35 S]methionine. Radiolawith HEK-293 lysates containing nNOS. A CAPON fusion protein beled nNOS was purified and mixed with His 6-CAPON as in (A), comprising the last 100 amino acids binds nNOS, as do fusion above. Bound nNOS was resolved by electrophoresis, and counts proteins comprising the last 13 or 20 amino acids of CAPON. A were determined on a PhosphoImager. CAPON fusion protein with the last 20 amino acids deleted no longer binds nNOS. Neither of the control proteins GST or GST-14-3-3 is able to bind nNOS. that these proteins interact physiologically and that the of nNOS between synaptic and nonsynaptic structures (Figure 7) . Presumably, NMDA receptor-mediated NO release into the synaptic space must be preceded by coprecipitated. In cells expressing HA-nNOS and myc-PSD95, antibodies to HA coprecipitate myc-PSD95 (Fig- the translocation of nNOS to synaptic structures by binding to PSD95. We propose that this process can be ure 6). When various amounts of CAPON cDNA containing expression plasmids are also transfected, HA blocked by CAPON's removal of nNOS from PSD95 and translocating nNOS into the cytoplasm or some other immunoprecipitates contain CAPON but substantially less PSD95. cellular compartment. In this manner, CAPON could lead to effective nNOS inhibition. Although CAPON does not inhibit nNOS catalytic activity directly (data not shown), Discussion CAPON would reduce the accessibility of nNOS to NMDA receptor-mediated calcium influx, thus diminishThe main finding of this study is the identification of a novel protein, CAPON, which interacts selectively with ing the capacity of nNOS to exert its physiologic or pathologic effects. Small molecules that specifically nNOS. The interaction of CAPON with nNOS is highly specific and has been verified by several methods of bind to nNOS in a manner similar to that of CAPON may be useful for blocking NO-mediated neuronal degenermonitoring protein-protein interactions. The similarities in neuronal localizations of CAPON and nNOS imply ation. by disrupting the ␤-sheet conformation of the C terminus, which might be achieved by phosphorylation at a distance. We have explored potential mechanisms that might
The nNOS PDZ domain is an example of a PDZ domain regulate the nNOS/CAPON interaction. For instance, we that binds to other PDZ domains. The region of nNOS phosphorylated nNOS in transfected HEK-293 cells by that possesses this property is the PDZ domain plus treatment with forskolin, phorbol esters, dibutyryl cyclic the adjacent ‫05ف‬ amino acids on the C side of the PDZ AMP, and 8-bromo-cyclic GMP and in vitro with purified domain (residues 1-150) (Brenman et al., 1996b) . The nNOS protein utilizing protein kinase C, protein kinase additional amino acids in this super-sized PDZ domain A, and calcium/calmodulin-dependent protein kinase may be required to accomodate larger ligands such as using methods described previously (Bredt et al., 1992) .
other PDZ domains. The finding in this report of another We have been unable to alter CAPON/nNOS interactions physiologic ligand for the PDZ domain, namely, the by any of these treatments (unpublished data).
C-terminal region of CAPON, raises the question of Conceivably, phosphorylation of CAPON regulates its whether the same or different portions of the nNOS PDZ interactions with nNOS. Recently, some of us showed domain account for the binding to two seemingly differthat phosphorylation of the n-2 serine in the potassium ent ligands. Because these interactions are mutually channel BIRK-2 regulates its binding to a PDZ domain exclusive, it is likely that the ligand-binding cleft in the in PSD95 (Cohen et al., 1996) . CAPON and several other PDZ domain mediates both interactions. Previously PDZ domain ligands (Songyang et al., 1997 ) lack a serine identified proteins that contain C-terminal PDZ-binding in this position and so must be regulated in some other sequences have been membrane-associated. By conmanner. One possible mechanism may be a regulation trast, CAPON is soluble. This demonstrates that PDZ of the ligand's C-terminal secondary structure. A recent domains may mediate purely cytosolic protein-protein crystallographic study of a PDZ domain complexed with interactions. a short cognate peptide shows that the peptide binds Stricker et al. (1997) recently characterized the speciin an antiparallel ␤-sheet conformation, with characterisficity of the nNOS PDZ-binding domain. These researchers tic ␤-sheet contacts between the peptide and a strand used a phage display method to identify NOS-binding of a ␤ sheet within the PDZ domain (see Doyle et al., peptides. Peptides ending in the sequence aspartate-1996). In a physiologic setting, the unbound cognate X-valine were found to be high-affinity ligands. Interestsequence may constitutively adopt a ␤-sheet conformaingly, unlike CAPON, these peptides did not bind the tion, with the other ␤ strands coming from other, possicanonical nNOS PDZ domain (amino acids 13-89) but bly distant, residues within the ligand protein's sebound the extended PDZ domain only (amino acids 1-150). quence. This ␤ sheet might constitute an endogenous This extended domain is the minimal sequence that mehigh-affinity ligand. This notion is supported by our obdiates PDZ-PDZ interactions. Presumably, the differservation that short, presumably unfolded, peptides ences in the binding sites in nNOS for the phage display comprising the C-terminal nine residues of CAPON bind peptide and CAPON account for the differences benNOS weakly, while 16 residue peptides are more potent tween the sequence specificity requirements for PDZcompetitors (IC 50 ϭ 10 M), although both are much less effective than 100 amino acid fusion proteins that are PDZ interactions and PDZ-CAPON interactions. , 100 mM NaCl, 10 mM reduced glutathione, and 2 mM EDTA). Transfections were performed with 10 g of each plasmid using General Methods and Materials Molecular biology reagents were from New England Biolabs (Bevthe calcium phosphate method. Following transfection, cells were sonicated in buffer A (50 mM , 100 mM NaCl, 2 mM erly, MA) and all other reagents were from Sigma (St. Louis, MO) except as indicated. Protein concentrations were determined by EDTA, and 1% Triton X-100) and cleared by centrifugation. This cellular lysate was incubated with GST fusion protein immobilized Bradford assay.
Experimental Procedures
on glutathione agarose for 1 hr at 4ЊC and washed extensively in HNTG buffer (20 mM HEPES [pH 7.4 ], 500 mM NaCl, 10% glycerol, Yeast Two-Hybrid Methods and 0.1% Triton X-100) five times, for 10 min per wash at room Two-hybrid screens and the construction of the parent vectors temperature. A GST-CAPON fusion protein consisting of amino pPC86, containing the GAL4 activation domain, and pPC97, conacids 379-503 was used for binding assays because it was more taining the GAL4 DNA-binding domain, have been described (Jaffrey soluble when expressed in bacteria than larger CAPON fusion proand Snyder, 1996) . Plasmid pBD-NOS(2-377) was prepared by the teins. insertion of an nNOS PCR product corresponding to amino acids For quantitative binding experiments, transfected cells were met-2-377 of rat nNOS into the SalI and BglII sites of pPC97, resulting abolically labeled overnight with 200 Ci [ 35 S]methionine, and nNOS in an open reading frame encoding a GAL4 BD-NOS fusion protein was purified by NADPH elution of 2Ј,5Ј-ADP ribose as described (Jaffrey and Snyder, 1996) . The nNOS fragment was constructed by previously . PCR using the following primers: 5Ј-GACTAGTCGACTGAAGAGAAC The material remaining on the resin was eluted with SDS-PAGE ACGTTTGGG-3Ј (coding strand) and 5Ј-TCTGCAGATCTCAGTGGG sample buffer, and nNOS was detected by immunoblot using anti-CCTTGGAGCCAAA-3Ј (noncoding strand).
bodies specific to each NOS isoform (Transduction Labs). A poly-A rat hippocampal cDNA library in pPC86 (Li et al., 1995) was clonal antiserum to CAPON was generated in rabbits by using a amplified once in DH10B (GIBCO BRL) as described (Jaffrey and His 6-tagged CAPON fusion protein. GST-CAPON was crosslinked Snyder, 1996) and transformed into yeast containing the pBDto glutathione agarose with dimethylpimelimidate, and this resin NOS(2-377) plasmid. pAD-CAPON1 and pAD-CAPON2 were identiwas used to purify CAPON antibody. To confirm the specificity of the fied as 0.8 kb and 1.9 kb clones, respectively, that activated lacZ antibody, immune serum was incubated with His 6-CAPON, which transcription and conferred histidine prototrophy in the presence of results in the abolishment of the signal. Incubation with His 6-FKBP pBD-NOS(2-377). Plasmids were sequenced by automated fluoreshas no effect on the signal (data not shown). cent sequencing of both strands. Yeast two-hybrid vectors conFor blot-overlay analysis, CAPON was inserted into pGEX-4T2, a taining the second PDZ domain of PSD93 (amino acids 116-421) derivative of PGEX4T2 in which two cyclic AMP-dependent protein and the three PDZ domains of PSD95 (amino acids 20-364) have kinase (PKA) sites were inserted between the GST moiety and the been described previously (Brenman et al., 1996a) . multiple cloning site (Jaffrey and Snyder, 1996) . Kinase reactions Truncated NOS fragments comprising amino acids 2-165 and and blot overlays were performed as described (Kavanaugh and 2-284 were generated by restriction of the initial NOS (2-377) PCR Williams, 1994). fragment with NcoI and AvaI, respectively, followed by Klenow filling in of that end and ligation into pPC97. Other truncated NOS fragImmunoprecipitations ments were prepared by PCR and have been described (Jaffrey and Immunoprecipitations were performed by homogenizing one rat cerSnyder, 1996). ebellum in 3 ml of lysis buffer followed by centrifugation at 100,000 ϫ g for 30 min at 4ЊC. Two hundred microliters of the supernatant was Cloning of CAPON cDNA incubated with 40 l of protein A-agarose (Oncogene Sciences, A CAPON DNA probe was generated by the random hexamer Cambridge, MA) and 5 g of the indicated antibody for 60 min at method using the pAD-CAPON2 cDNA as a template. This probe 4ЊC. The resins were then washed with IP wash buffer (50 mM Triswas used to screen a rat brain ZAPII cDNA library (Stratagene) HCl [pH 7.7] , 400 mM NaCl, and 2 mM EDTA) six times and eluted using methods described by the manufacturer. A 2.1 kb cDNA was in 60 l of 1ϫ SDS-PAGE sample buffer by boiling. Western blots isolated that overlapped with the pAD-CAPON2 clone. The cDNAs were performed using an nNOS-specific monoclonal antibody were ligated at an overlapping XbaI site to produce the full-length (Transduction Labs) or a PKC-␤ I/II monoclonal antibody (Santa 2,812 bp cDNA and subcloned into pCMV for eukaryotic expression.
Cruz Biotechnology, Santa Cruz, CA). The immunoprecipitating antiThe human CAPON EST was the sole CAPON homolog identified bodies used as controls were from Santa Cruz Biotechnology. in a BLAST seacrh (Altschul et al., 1990) . I.M.A.G.E. consortium For experiments utilizing 2Ј,5Ј-ADP-Sepharose (Pharmacia), tis-(http://www.bio.llnl.gov/bbrp/image/image.html/) clone 34183 (Lennon sues were prepared identically as for immunoprecipitations, except et al., 1996) was purchased from Research Genetics (Huntsville, AL). mouse cerebella were used, and the homogenization volume was 400 l per cerebellum. Supernatants were incubated with 100 l of RNA (Northern) Blotting affinity resin. Incubations and washes were performed identically Thirty micrograms of whole RNA was isolated from rat tissues using as for immunoprecipitations. The generation of mice with a targeted the Triazol reagent (GIBCO BRL) and separated on agarose-formaldeletion of nNOS has been described previously (Huang et al., 1993) . dehyde gels. RNA was transferred to Hybond Nϩ membranes (Amersham), and a DNA probe, generated using the random hexamer Immunohistochemistry method with the two-hybrid CAPON cDNA as a template, was hyAdult Sprague-Dawley rats (200-250 g) were obtained from Charles bridized in Rapid-hyb buffer (Amersham) overnight at 65ЊC. The
River and housed at the Johns Hopkins Animal Care Facility. A blots were subsequently washed sequentially in 2ϫ SSC with 0.1% polyclonal antiserum to the C-terminal region of human nNOS (resi-SDS, once at room temperature for 15 min, 1ϫ SSC with 1% SDS dues 1419-1433) was kindly provided by J. Spangenberg (IncStar, twice at 65ЊC, 0.1ϫ SSC with 1% SDS twice at 65ЊC, and then with Stillwater, MN). The peroxidase Elite staining kit was from Vector 0.1ϫ SSC with 5% SDS twice at 65ЊC. The blot was apposed to film Laboratories. for 4 days at Ϫ80ЊC to visualize the bands.
Anesthetized rats were perfused through the left ventricle with 50 ml of 0.9% NaCl followed by 500 ml of 4% paraformaldehyde in 0.1 M phosphate buffer (PB) (pH 7.4). The brains were removed, cut GST Fusion Protein Binding Assays GST fusion proteins were prepared in BL21(DE3) Escherichia coli into saggital blocks, and postfixed in 4% paraformaldehyde in 0.1 M PB for 4 hr at room temperature. Blocks were cryoprotected for (Novagen) with glutathione agarose as an affinity resin for purification (Smith and Johnson, 1988) , except that bacterial pellets were 2 days at 4ЊC in 50 mM sodium phosphate (pH 7.4)/0.1 M NaCl/20% (v/v) glycerol. Brain sections, 40 m thick, were cut on a sliding sonicated in lysis buffer (50 mM , 100 mM NaCl, and 2 mM EDTA), supernatants were adjusted to 1% Triton X-100, microtome. Free-floating sections were incubated in PBS (10 mM [pH 7.4]/0.19 M NaCl) containing 4% normal goat serum (Jackson washes were done in 50 mM Tris-HCl (pH 7.7), 500 mM NaCl, 2 mM EDTA, and 1% Triton X-100, and protein was purified with elution Labs) and 0.2% Triton X-100 for 45 min and then incubated overnight
